| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Epidemiology (Drs. Chen, Belle, Cauley, and Ganguli), Graduate School of Public Health, the Alzheimer’s Disease Research Center (Dr. DeKosky), and the Departments of Psychiatry (Drs. Ratcliff, DeKosky, and Ganguli) and Neurology (Dr. DeKosky), School of Medicine, University of Pittsburgh; and HealthSouth Harmarville Rehabilitation Hospital (Dr. Ratcliff), Pittsburgh, PA.
Address correspondence and reprint requests to Dr. Mary Ganguli, Western Psychiatric Institute and Clinic, 3811 O’Hara Street, Pittsburgh, PA 15213-2593; e-mail: gangulim{at}msx.upmc.edu
OBJECTIVE: To identify the most accurate cognitive measures in discriminating between individuals with presymptomatic AD and individuals who remained nondemented.
METHODS: During a 10-year prospective community study, 120 nondemented subjects completed a battery of standard cognitive tests and clinically manifested AD 1.5 years later. Performance on each of 16 cognitive tests was compared between these 120 presymptomatic cases and 483 controls who remained nondemented over the 10-year follow-up period. The area under the receiver operating characteristic (AUC) curve for each test was used to measure its accuracy of discrimination between cases and controls.
RESULTS: Among the 16 neuropsychological tests, Word List Delayed Recall discriminated best between cases and controls (AUC = 0.806), followed by the Word List 3rd Learning Trial (0.787), Word List 1st Learning Trial (0.774), and Trail-making Test B (0.773), compared to the Mini-Mental State Examination (MMSE) (0.726). Both Word List Delayed Recall and Word List 3rd Learning Trial were significantly more accurate than the MMSE. The combination of Word List Delayed Recall and Trail-making Test B comprised the optimal set of cognitive measures, with the highest AUC (0.852).
CONCLUSION: Measures of delayed recall and executive functions were the best discriminators between those who would manifest AD 1.5 years later and those who would remain nondemented. These findings are relevant for the early detection of AD and, therefore, for prevention and early intervention trials. Executive dysfunction may be a subtle manifestation of incipient AD, along with memory dysfunction.
This article has been cited by other articles:
|
|
 |
|
  D Verbaan, J Marinus, M Visser, S M van Rooden, A M Stiggelbout, H A M Middelkoop, and J J van Hilten Cognitive impairment in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1182 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mejia, A. Miguel, L. M. Gutierrez, A. R. Villa, and F. Ostrosky-Solis Comparative analysis of cognitive impairment among Mexicans and Spanish-speaking immigrant's elders. J Aging Health, April 1, 2006; 18(2): 292 - 314. [Abstract] [PDF]
|
|
|
|
 |
|
 R. J. Kryscio, F. A. Schmitt, J. C. Salazar, M. S. Mendiondo, and W. R. Markesbery Risk factors for transitions from normal to mild cognitive impairment and dementia Neurology, March 28, 2006; 66(6): 828 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gatz, A. Fiske, C. A. Reynolds, B. Johansson, L. Fratiglioni, and N. L. Pedersen Performance on Neurocognitive Tests by Co-twins to Dementia Cases Compared to Normal Control Twins J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 202 - 207. [Abstract] [PDF]
|
|
|
|
|
|
J. J. McArdle, B. J. Small, L. Backman, and L. Fratiglioni Longitudinal Models of Growth and Survival Applied to the Early Detection of Alzheimer's Disease J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 234 - 241. [Abstract] [PDF]
|
|
|
|
|
|
A Nordlund, S Rolstad, P Hellstrom, M Sjogren, S Hansen, and A Wallin The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition J. Neurol. Neurosurg. Psychiatry, November 1, 2005; 76(11): 1485 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Ringman, C. Diaz-Olavarrieta, Y. Rodriguez, M. Chavez, L. Fairbanks, F. Paz, A. Varpetian, H. C. Maldonado, M. A. Macias-Islas, J. Murrell, et al. Neuropsychological function in nondemented carriers of presenilin-1 mutations Neurology, August 23, 2005; 65(4): 552 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Feldman and C. Jacova Mild Cognitive Impairment Am J Geriatr Psychiatry, August 1, 2005; 13(8): 645 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Tornatore, E. Hill, J. A. Laboff, and M. E. McGann Self-Administered Screening for Mild Cognitive Impairment: Initial Validation of a Computerized Test Battery J Neuropsychiatry Clin Neurosci, February 1, 2005; 17(1): 98 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Garcia, Y. Haron, K. Pulman, L. Hua, and M. Freedman Increases in Homocysteine Are Related to Worsening of Stroop Scores in Healthy Elderly Persons: A Prospective Follow-Up Study J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2004; 59(12): 1323 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Cervilla, M Prince, S Joels, S Lovestone, and A Mann Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S.C. Korf, L.-O. Wahlund, P. J. Visser, and P. Scheltens Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment Neurology, July 13, 2004; 63(1): 94 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. DeKosky and K. Marek Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders Science, October 31, 2003; 302(5646): 830 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Helmuth Detangling Alzheimer's Disease Sci. Aging Knowl. Environ., October 29, 2003; 2003(43): oa2 - 2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Palmer, L. Backman, B. Winblad, and L. Fratiglioni Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study BMJ, February 1, 2003; 326(7383): 245 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chen, G. Ratcliff, S. H. Belle, J. A. Cauley, S. T. DeKosky, and M. Ganguli Patterns of Cognitive Decline in Presymptomatic Alzheimer Disease: A Prospective Community Study Arch Gen Psychiatry, September 1, 2001; 58(9): 853 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Small, L. Fratiglioni, and L. Backman Canaries in a Coal Mine: Cognitive Markers of Preclinical Alzheimer Disease Arch Gen Psychiatry, September 1, 2001; 58(9): 859 - 860. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Tierney, P. Chen, S. T. DeKosky, and M. Ganguli Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented Neurology, July 10, 2001; 57(1): 163 - 164. [Full Text] [PDF]
|
|
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
